CDMRP Pancreatic Cancer Research Program Translational Research Partnership Award

קרןUS Department of Defense
סוגResearch Grants
תאריך אחרון25/08/2020
פקולטהLife Sciences, Medicine, Social Sciences

The FY20 PCARP Translational Research Partnership Award supports partnerships between clinicians and research scientists. Multi-institutional and multi-discipline partnerships are strongly encouraged. At least one partner must have expertise either in pancreatic cancer research or pancreatic cancer patient care.


FY20 PCARP Focus Areas.
  • Understanding precursors, origins, and early progression of pancreatic cancer
  • Understanding the events that promote pancreatic cancer metastasis
  • Understanding the relationship between oncogenic signaling and the tumor microenvironment that drives drug resistance and therapeutic response
  • Integration of biologic and imaging biomarkers to drive more precise and earlier detection and prognosis
  • Defining viable tumor burden
  • Supportive care and patient-reported outcomes, quality of life, and perspectives during treatment and survivorship
  • New drug development targeted toward cancer sensitivity and resistance mechanisms including immune mechanisms of resistance
  • Development of pharmacological, immunological, or genetic interception approaches



Funding: $750,000 total

Duration: 3 years 



Research Authority due date: 17.8.20

Pre application (required) due date: 25.8.20

Full proposal due date: 20.11.20

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 05/07/2020
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive